These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11550941)

  • 21. A simple and flexible graphical approach for adaptive group-sequential clinical trials.
    Sugitani T; Bretz F; Maurer W
    J Biopharm Stat; 2016; 26(2):202-16. PubMed ID: 25372071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials and rare diseases.
    Gerss JW; Köpcke W
    Adv Exp Med Biol; 2010; 686():173-90. PubMed ID: 20824446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A general statistical principle for changing a design any time during the course of a trial.
    Müller HH; Schäfer H
    Stat Med; 2004 Aug; 23(16):2497-508. PubMed ID: 15287080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A general formulation for a one-sided group sequential design.
    Moser BK; George SL
    Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.
    Emerson SC; Rudser KD; Emerson SS
    Stat Med; 2011 May; 30(11):1199-217. PubMed ID: 21538450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A practical guide to Bayesian group sequential designs.
    Gsponer T; Gerber F; Bornkamp B; Ohlssen D; Vandemeulebroecke M; Schmidli H
    Pharm Stat; 2014; 13(1):71-80. PubMed ID: 24038922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A unifying family of group sequential test designs.
    Kittelson JM; Emerson SS
    Biometrics; 1999 Sep; 55(3):874-82. PubMed ID: 11315020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.
    Jennison C; Turnbull BW
    Biometrics; 1993 Sep; 49(3):741-52. PubMed ID: 8241370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive designs with correlated test statistics.
    Götte H; Hommel G; Faldum A
    Stat Med; 2009 May; 28(10):1429-44. PubMed ID: 19226563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of experiments with adaptive interim analyses.
    Bauer P; Köhne K
    Biometrics; 1994 Dec; 50(4):1029-41. PubMed ID: 7786985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-designing trial combined with classical group sequential monitoring.
    Yin G; Shen Y
    J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of methods for adaptive treatment selection.
    Friede T; Stallard N
    Biom J; 2008 Oct; 50(5):767-81. PubMed ID: 18932136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On group sequential procedures under variance heterogeneity.
    Hussein A; Carriere KC
    Stat Methods Med Res; 2005 Apr; 14(2):121-8. PubMed ID: 15807147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A regulatory view on adaptive/flexible clinical trial design.
    Hung HM; O'Neill RT; Wang SJ; Lawrence J
    Biom J; 2006 Aug; 48(4):565-73. PubMed ID: 16972707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal clinical trials with adaptive choice of follow-up time.
    Jeffries N; Geller NL
    Biometrics; 2015 Jun; 71(2):469-77. PubMed ID: 25818116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.
    Brannath W; Zuber E; Branson M; Bretz F; Gallo P; Posch M; Racine-Poon A
    Stat Med; 2009 May; 28(10):1445-63. PubMed ID: 19266565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On sample size and inference for two-stage adaptive designs.
    Liu Q; Chi GY
    Biometrics; 2001 Mar; 57(1):172-7. PubMed ID: 11252594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.